Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating Activities    
Net loss [1] $ (25,428) $ (207,889)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities [1] (210,813) 323,571
Net cash provided by (used in) operating activities [1] (236,241) 115,682
Investing Activities    
Purchases and originations of loans held for investment [1] (1,366,450) (1,577,211)
Proceeds/payments received on loans held for investment [1] 1,086,741 895,538
Purchases and originations of loans held for investment, subject to nonrecourse debt [1] (22,236) (47,505)
Proceeds/payments on loans held for investment, subject to nonrecourse debt [1] 493,853 738,395
Proceeds on sale of mortgage servicing rights (“MSR”) [1] 5,516 84,029
Acquisition of American Advisors Group net assets [1] 0 (140,854)
Proceeds from sale of businesses [1] 3,000 5,262
Other investing activities, net [1] (166) (3,974)
Net cash provided by (used in) investing activities [1] 200,258 (46,320)
Financing Activities    
Proceeds from issuance of HMBS related obligations [1] 971,926 921,390
Payments on HMBS related obligations [1] (1,039,423) (887,395)
Proceeds from issuance of nonrecourse debt [1] 388,203 1,187,235
Payments on nonrecourse debt [1] (439,130) (878,800)
Proceeds from other financing lines of credit [1] 2,745,746 2,556,906
Payments on other financing lines of credit [1] (2,593,381) (2,940,162)
Changes in notes payable [1] 27,047 12,790
Other financing activities, net [1] (3,146) (869)
Net cash provided by financing activities [1] 57,842 1,095
Effect of exchange rate changes on cash and cash equivalents (47) 19
Net increase in cash and cash equivalents and restricted cash 21,812 70,476
Cash and cash equivalents and restricted cash, beginning of period [1] 224,801 277,436
Cash and cash equivalents and restricted cash, end of period [1] 246,613 347,912
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 46,509 82,058
Restricted cash 200,104 265,854
Total cash, cash equivalents, and restricted cash in statement of cash flows [1] 246,613 347,912
Supplementary Cash Flows Information    
Cash paid for interest 178,646 140,159
Loans transferred to loans held for sale, at fair value, from loans held for investment, at fair value 5,424 3,685
Class A Common Stock    
Financing Activities    
Issuance of Class A Common Stock [1] $ 0 $ 30,000
[1] Amounts presented contain results from both continuing and discontinued operations. Refer to Note 4 - Discontinued Operations for additional information regarding cash flow associated with the results of discontinued operations.